GET DAILY SIGNALSUiPath (PATH) Stock Rises +31.8% Over 30 Days: What’s Fueling the Recovery
Key Takeaways
- PATH shares climbed approximately 31.8% over the 30-day window, from a closing price of $12.15 on July 17, 2026, to $16.01 on August 14, 2026.
- The advance extends a broader recovery, with the stock up roughly 52% over the trailing three months after touching its 52-week low of $9.20 in mid-May.
- Improving sentiment around enterprise AI and agentic automation, a constructive analyst target revision, and elevated trading volume supported the move.
- Fundamentals remain a key anchor: fiscal 2027 first-quarter revenue rose 17.3% year over year to $418.4 million, and management raised its full-year revenue outlook.
- Wall Street remains measured, with a consensus Hold rating and average 12-month price targets near $13.87, below the latest close.
- Price swings have been sharp, including a late-July pullback toward $10.20 and an August acceleration above $16.
UiPath (PATH) Company Overview and Market Position
UiPath, Inc. is a global enterprise automation and artificial intelligence software company. Its Business Automation Platform combines robotic process automation with AI-powered capabilities such as document understanding, process mining, test automation, and agentic orchestration tools including Maestro. The company serves large organizations across financial services, healthcare, government, manufacturing, and other industries that use automation to streamline repetitive, complex, and decision-intensive workflows.
UiPath operates primarily through a subscription-based software model and is followed closely by investors as a barometer for enterprise adoption of AI-driven automation. The company has a market capitalization of roughly $8.3 billion and maintains a strong balance sheet, with approximately $1.4 billion in cash and cash equivalents and no outstanding debt as of its latest disclosures. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
UiPath (PATH) Stock Price Performance: Last 30 Days vs. Quarter
Over the most recent 30-day period, PATH moved from a closing price of $12.15 on July 17, 2026, to $16.01 on August 14, 2026. Because 30 calendar days before August 17 falls on a Saturday, the nearest prior trading session close is used. The resulting gain of about 31.8% places the move firmly in price-movement territory.
The path higher was not linear. Shares pulled back sharply in late July, falling from $12.04 on July 21 to $10.20 by July 23, before recovering into month-end. The rally then accelerated in August: the stock rose 8.0% to $14.10 on August 4 and climbed another 9.3% to $16.68 on August 13 on elevated volume, before settling at $16.01 on August 14.
The quarterly trend is even stronger. From a closing price of $10.55 on May 19, 2026, PATH advanced about 51.8% to the latest close. The stock bottomed near $9.20 on an intraday basis in mid-May and has since traded above both its 50-day moving average of roughly $11.97 and its 200-day moving average of roughly $11.50, reflecting a decisive shift in trend.
What Drove PATH Stock Price in the Last 30 Days
The 30-day advance was supported by several verified factors. On August 14, RBC Capital analyst Matthew Hedberg maintained a Sector Perform rating and raised the firm's price target to $15 from $12. The note, which previewed second-quarter results for software names, pointed to more constructive checks and indicated that upside to consensus estimates appeared more likely heading into the second half. The firm also noted that PATH shares had risen about 30% since first-quarter earnings.
Broader investor enthusiasm for AI and agentic automation also played a role. UiPath's positioning in enterprise workflow automation, including agentic orchestration and AI-native case management capabilities, has kept the stock in the center of the AI-software conversation. Institutional ownership remains substantial at approximately 62.5%, and recent regulatory filings showed both accumulation and trimming among large investors as the stock repriced. From what I see, checking signals with Tickeron’s AI Daily Buy/Sell Signals helped put the volume surge in context.
Technically, the breakout above the 50-day and 200-day moving averages attracted momentum-oriented activity, with trading volumes expanding notably during the August advance. At the same time, the rally has moved the stock above the consensus average price target, leaving valuation as a source of debate rather than a catalyst.
What Drove PATH Stock Performance Over the Last Quarter
The three-month recovery traces back to UiPath's fiscal 2027 first-quarter results, reported on May 28, 2026. Revenue of $418.4 million grew 17.3% year over year and exceeded consensus estimates of approximately $397.5 million. Non-GAAP earnings per share came in at $0.15, and management raised its full-year fiscal 2027 revenue guidance to approximately $1.78 billion. Annual recurring revenue reached roughly $1.9 billion, up about 12% year over year.
Those results marked an inflection after a prolonged period of investor skepticism that had pushed the stock toward its 52-week low in mid-May. Since then, product momentum around agentic AI, a strong cash position, and steadier recurring-revenue trends have supported the broader narrative of improving execution. Analyst actions have been mixed but gradually constructive, with targets moving from a tightly clustered $12-to-$15 range into the low-to-mid teens.
PATH Stock Forecast Drivers: What Investors Should Watch Next
The next major catalyst is UiPath's fiscal 2027 second-quarter earnings release and updated guidance. Investors will focus on annual recurring revenue growth, net new ARR, net revenue retention, and whether agentic AI adoption is translating into measurable monetization. Commentary on enterprise software budgets, deal sizes, and public-sector demand will also matter.
Beyond earnings, the stock's relationship to analyst price targets and valuation multiples will remain a key watch item. Macroeconomic conditions, interest-rate expectations, and overall software-sector sentiment could influence momentum, while competition from large platform vendors and changing AI pricing models remain important risk factors. Investors should monitor these developments without treating any single data point as a definitive signal. I’m watching this closely as the next earnings could clarify the sustainability of the recent move.
Using Tickeron’s AI Tools for Deeper Analysis
In my research process, I frequently review Tickeron’s Trending AI Robots page to explore systematic strategies that align with names like PATH. The selection highlights top-performing bots across various risk profiles and holding periods, giving a practical way to compare approaches without relying on any single signal. This helps put price action and volume trends into a broader, data-driven perspective.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PATH in +2.58% Uptrend, growing for three consecutive days on October 26, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PATH advanced for three days, in 236 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Aroon Indicator entered an Uptrend today. In 122 of 173 cases where PATH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In 71 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for PATH turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 38 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
PATH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.477) is normal, around the industry mean (16.360). P/E Ratio (19.403) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (104.492).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. PATH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement